定价200多万的日本心衰+帕金森iPS细胞疗法落地,但正式进入医保 episode artwork

EPISODE · Jul 31, 2026 · 6 MIN

定价200多万的日本心衰+帕金森iPS细胞疗法落地,但正式进入医保

from 天方烨谈

近日,日本将由iPS(诱导多能干细胞)制备的心肌细胞片产品纳入公共医疗保险体系,这也是继今年5月帕金森治疗产品落地后,日本第二款进入全民医保的iPS再生医疗产品。曾经专属于极少数高净值人群的尖端再生医学,正在通过医保制度的普惠设计,真正走向普通重症患者。

Episode metadata supplied by the publisher feed · Published Jul 31, 2026

Embed this episode

Ready to play

定价200多万的日本心衰+帕金森iPS细胞疗法落地,但正式进入医保

0:00 6:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 天方烨谈?

This episode is 6 minutes long.

When was this 天方烨谈 episode published?

This episode was published on July 31, 2026.

Can I download this 天方烨谈 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!